Marcin Holota
Banacha St. 12/16
Lodz, LD 90237, Poland
Lodz, LD 90237, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Copper metallodendrimers effectively deliver proapoptotic siRNA to human liver carcinoma HepG2 cells.
Journal: International journal of pharmaceutics
Published: March 27, 2026
Nature-Inspired Strategies in Cancer Management: The Potential of Plant Extracts in Modulating Tumour Biology.
Journal: International journal of molecular sciences
Published: June 16, 2025
Lipid-coated ruthenium dendrimer conjugated with doxorubicin in anti-cancer drug delivery: Introducing protocols.
Journal: Colloids and surfaces. B, Biointerfaces
Published: April 04, 2023
Combination of Copper Metallodendrimers with Conventional Antitumor Drugs to Combat Cancer in In Vitro Models.
Journal: International journal of molecular sciences
Published: January 22, 2023
Carbosilane ruthenium metallodendrimer as alternative anti-cancer drug carrier in triple negative breast cancer mouse model: A preliminary study.
Journal: International journal of pharmaceutics
Published: November 29, 2022
Combined therapy of ruthenium dendrimers and anti-cancer drugs against human leukemic cells.
Journal: Dalton transactions (Cambridge, England : 2003)
Published: July 13, 2021
Organometallic dendrimers based on Ruthenium(II) N-heterocyclic carbenes and their implication as delivery systems of anticancer small interfering RNA.
Journal: Journal of inorganic biochemistry
Published: November 02, 2020
Heterofunctional ruthenium(II) carbosilane dendrons, a new class of dendritic molecules to fight against prostate cancer.
Journal: European journal of medicinal chemistry
Published: July 01, 2020
In Vitro Anticancer Properties of Copper Metallodendrimers.
Journal: Biomolecules
Published: March 26, 2019
Showing 1-12 of 12
Last Updated: 09/26/2026